Literature DB >> 8692987

Molecular cloning of a rat chromosome putative recombinogenic sequence homologous to the hepatitis B virus encapsidation signal.

H Aoki1, K Kajino, Y Arakawa, O Hino.   

Abstract

Previously, we reported that a 61-bp subgenomic HBV DNA sequence (designated as 15AB, nt 1855-1915) is a hot spot for genomic recombination and that a cellular protein binding to 15AB may be the putative recombinogenic protein. In the present study, we established the existence of a 15AB-like sequence in human and rat chromosomal DNA by Southern blot analysis. The 15AB-like sequence isolated from the rat chromosome demonstrated a 80.9% identity with 5'-CCAAGCTGTGCCTTGGGTGGC-3', at 1872-1892 of the hepatitis B virus genome, thought to be the essential region for recombination. Interestingly, this 15AB-like sequence also contained the pentanucleotide motifs GCTGG and CCAGC as an inverted repeat, part of the chi known hot spot for recombination in Escherichia coli. Importantly, a portion of the 15AB-like sequence is homologous (82.1%, 23/28 bp) to break point clusters of the human promyelocytic leukemia (PML) gene, characterized by a translocation [t(15;17)], and to rearranged mouse DNA for the immunoglobulin kappa light chain. Moreover, 15AB and 15AB-like sequences have striking homologies (12/15 = 80.0% and 13/15 = 86.7%, respectively) to the consensus sequence for topoisomerase II. Our present results suggest that this 15AB-like sequence in the rat genome might be a recombinogenic candidate triggering genomic instability in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692987      PMCID: PMC38978          DOI: 10.1073/pnas.93.14.7300

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  HBx gene of hepatitis B virus induces liver cancer in transgenic mice.

Authors:  C M Kim; K Koike; I Saito; T Miyamura; G Jay
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

Review 2.  The clinical significance of molecular variation within the hepatitis B virus genome.

Authors:  J L Brown; W F Carman; H C Thomas
Journal:  Hepatology       Date:  1992-01       Impact factor: 17.425

3.  Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.

Authors:  A Buchmann; R Bauer-Hofmann; J Mahr; N R Drinkwater; A Luz; M Schwarz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

4.  Breakpoint clusters of the PML gene in acute promyelocytic leukemia: primary structure of the reciprocal products of the PML-RARA gene in a patient with t(15;17).

Authors:  S Dong; J P Geng; J H Tong; Y Wu; J R Cai; G L Sun; S R Chen; Z Y Wang; C J Larsen; R Berger
Journal:  Genes Chromosomes Cancer       Date:  1993-03       Impact factor: 5.006

5.  Determination of a putative recombinogenic human hepatitis B virus sequence and its binding cellular protein.

Authors:  K Kajino; Y Hotta; O Hino
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

6.  Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNA.

Authors:  O Hino; S Tabata; Y Hotta
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

7.  Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.

Authors:  Y Murakami; K Hayashi; S Hirohashi; T Sekiya
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

8.  Independently derived murine glomerular immune deposit-forming anti-DNA antibodies are encoded by near-identical VH gene sequences.

Authors:  M S Katz; M H Foster; M P Madaio
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

9.  A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA.

Authors:  M Junker-Niepmann; R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

10.  Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice.

Authors:  D M Tillman; N T Jou; R J Hill; T N Marion
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  6 in total

1.  Identification of the lactococcal exonuclease/recombinase and its modulation by the putative Chi sequence.

Authors:  M el Karoui; D Ehrlich; A Gruss
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

2.  Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene.

Authors:  Fuminaka Sugauchi; Etsuro Orito; Takafumi Ichida; Hideaki Kato; Hiroshi Sakugawa; Shinichi Kakumu; Takafumi Ishida; Anuchit Chutaputti; Ching-Ling Lai; Ryuzo Ueda; Yuzo Miyakawa; Masashi Mizokami
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Interaction of the hepatitis B spliced protein with cathepsin B promotes hepatoma cell migration and invasion.

Authors:  Wan-Nan Chen; Jin-Yan Chen; Bo-Yan Jiao; Wan-Song Lin; Yun-Li Wu; Ling-Ling Liu; Xu Lin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

Review 4.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

Review 5.  Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence.

Authors:  Zhong-Ming Tan; Bei-Cheng Sun
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

6.  Tissue specificity of DNA damage response and tumorigenesis.

Authors:  Siman Sun; Michael D Osterman; Mo Li
Journal:  Cancer Biol Med       Date:  2019-08       Impact factor: 4.248

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.